Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Atkins

Showing results (81-90 of 735) with videos related to

Pageof 74
Sort By:
Current Opinion in Nephrology and Hypertension|June 10, 2000
Towards targeted treatment of glomerulonephritisR C Atkins, A K Singh
Transplantation Proceedings|August 1, 1984
Immunohistologic analysis of the cell surface antigens of human dendritic cells using monoclonal antibodiesW W Hancock, R C Atkins
Immunology and Cell Biology|June 1, 1991
Deoxyspergualin inhibits cytotoxic T lymphocytes but not NK or LAK cellsP G Kerr, R C Atkins
Biochemical Pharmacology|May 15, 1986
Differences in Ca2+ entry blockers revealed by effects on adenosine- and adrenergic- receptors and cyclic AMP levels of [2-3H]adenine-prelabeled vesicles prepared from guinea pig brainS Psychoyos, M Bax, C Atkins
Lancet (London, England)|May 25, 2005
GlomerulonephritisS J Chadban, R C Atkins
Contributions to Nephrology|June 11, 2011
Epidemiology of diabetic nephropathyAnne T Reutens, Robert C Atkins
Transplantation|July 1, 1989
The effects of OKT3 therapy on infiltrating lymphocytes in rejecting renal allograftsP G Kerr, R C Atkins
International Journal of Clinical Pharmacology and Therapeutics|September 24, 2010
Postural orthostatic tachycardia syndrome: a case report of palpitations and dizziness following prophylactic mefloquine useA Bhanji, C Atkins, M Karim
The Journal of Experimental Medicine|March 1, 1975
Early cellular events in a systemic graft-vs.-host reaction. I. The migration of responding and nonresponding donor lymphocytesR C Atkins, W L Ford
Drugs|December 2, 2006
Blood pressure lowering for the prevention and treatment of diabetic kidney diseaseMerlin C Thomas, Robert C Atkins
Pageof 74

Showing results (81-90 of 735) with videos related to

Sort By:
Pageof 74
Current Opinion in Nephrology and Hypertension|June 10, 2000
Towards targeted treatment of glomerulonephritisR C Atkins, A K Singh
Transplantation Proceedings|August 1, 1984
Immunohistologic analysis of the cell surface antigens of human dendritic cells using monoclonal antibodiesW W Hancock, R C Atkins
Immunology and Cell Biology|June 1, 1991
Deoxyspergualin inhibits cytotoxic T lymphocytes but not NK or LAK cellsP G Kerr, R C Atkins
Biochemical Pharmacology|May 15, 1986
Differences in Ca2+ entry blockers revealed by effects on adenosine- and adrenergic- receptors and cyclic AMP levels of [2-3H]adenine-prelabeled vesicles prepared from guinea pig brainS Psychoyos, M Bax, C Atkins
Lancet (London, England)|May 25, 2005
GlomerulonephritisS J Chadban, R C Atkins
Contributions to Nephrology|June 11, 2011
Epidemiology of diabetic nephropathyAnne T Reutens, Robert C Atkins
Transplantation|July 1, 1989
The effects of OKT3 therapy on infiltrating lymphocytes in rejecting renal allograftsP G Kerr, R C Atkins
International Journal of Clinical Pharmacology and Therapeutics|September 24, 2010
Postural orthostatic tachycardia syndrome: a case report of palpitations and dizziness following prophylactic mefloquine useA Bhanji, C Atkins, M Karim
The Journal of Experimental Medicine|March 1, 1975
Early cellular events in a systemic graft-vs.-host reaction. I. The migration of responding and nonresponding donor lymphocytesR C Atkins, W L Ford
Drugs|December 2, 2006
Blood pressure lowering for the prevention and treatment of diabetic kidney diseaseMerlin C Thomas, Robert C Atkins
Pageof 74